John Krystal
InvestorFounderAdvisor at PsyMed Ventures · Co-founder & CEO at Freedom Biosciences
West Haven, Connecticut, United States
FoundedFreedom Biosciences
Find your path to John
76 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
Karthik ArdhanareeswaranunlockedJohn: together at Yale University School of Medicine (2012–2015)
×8John: together at Yale University School of Medicine
×3John: together at Freedom Biosciences
About
Specialist in translational psychiatry and neuroscience at Yale University School of Medicine and Chief of Psychiatry at Yale-New Haven Hospital.
Co-founder & CEO at Freedom Biosciences
Intro paths
→
In turn, John can intro founders to Freedom Biosciences's investors below.
Freedom Biosciences's investors · 8
Co-founders at Freedom Biosciences
DB

Dina BurkitbayevaCo-founder
Experience
- Yale University School of MedicineProfessorcurrent1988 — present
Colleagues at PsyMed Ventures
Alex Amen
Advisor at PsyMed Ventures
Angel Gambino
Founder at Angel Club
Chrystal Mavros
Advisor at PsyMed Ventures
Danny Carbonero
Investment Associate at PsyMed Ventures
Dina Burkitbayeva
Co-Founder at PsyMed Ventures
Garri Zmudze
Managing Partner at LongeVC
Graham Pechenik
Advisor at PsyMed Ventures
Greg Kubin
General Partner and Co-Founder at PsyMed Ventures
Frequently asked questions
- Who is John Krystal?
- Specialist in translational psychiatry and neuroscience at Yale University School of Medicine and Chief of Psychiatry at Yale-New Haven Hospital.
- Where does John Krystal work?
- John Krystal is Co-founder & CEO of Freedom Biosciences and Advisor at PsyMed Ventures.
- What companies did John Krystal found?
- John Krystal founded Freedom Biosciences.
Founder mafias
PsyMed Ventures mafia6
Also came through, then founded or led a company.
Shared employers
Also worked at Yale University School of Medicine68
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University PartnersDavid Rosenthal, MDVenture Partner at AlleyCorpAlley (Welsh) OlshanskyAdvisor at Casdin CapitalSophie RobinsonSenior Associate at Cure VenturesMichael RechtChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures
+ 62 more

















